SpacePharma, a deeptech specializing in the development of research and production laboratories in orbit – also known as mini laboratories of the size of a shoe box to be sent into space – has recently settled their European office at the International Space University’s (ISU) central campus in Strasbourg, France.
At a recent press event held at ISU, Dr. Paul Kamoun, former ISU faculty, and director of the European branch of SpacePharma said:
“The notoriety of the International Space University, the ISU Incubator, the attractiveness of the Eurometropolis of Strasbourg, and the influence of the health competitiveness cluster “BioValley France” played a major role in SpacePharma’s decision to locate its European office on the central campus of ISU”.
The main reasons why SpacePharma Europe chose to settle at ISU are:
the ISU Incubator which guarantees direct access to the international space community composed of industrial, institutional, or academic companies as well as resident experts, universities, laboratories and innovation clusters, and therefore allowing SpacePharma to find new partners.
the strong support of the Eurometropolis of Strasbourg.
Will tomorrow’s drug treatments be produced in space? “Made in Space” for medicine is a new playground for research and innovation!
“Lack of gravity/microgravity in space, opens the way to innovations in the pharmaceutical domain also, that we could not have imagined on Earth…” as explained by Dr. Paul Kamoun in the documentary by FranceInfo (France 3 GrandEst, starting at 8:13min).
At a recent press event held at ISU, Dr. Paul Kamoun, former ISU faculty, and director of the European branch of SpacePharma said:
“The notoriety of the International Space University, the ISU Incubator, the attractiveness of the Eurometropolis of Strasbourg, and the influence of the health competitiveness cluster “BioValley France” played a major role in SpacePharma’s decision to locate its European office on the central campus of ISU”.
This is an overview of the Space and Clinical Operations Division whose mission is to optimize the health, fitness and well-being of flight crews, their dependents and employees of the Johnson Space Center and White Sands Space Harbor.
왜 우주까지 가서 약을 만들어야 되냐구요?
From Virginia, 윤학순 CEO
왜 우주까지 가서 약을 만들어야 되냐구요? From Virginia, 윤학순 CEO
SpacePharma, a deeptech specializing in the development of research and production laboratories in orbit – also known as mini laboratories of the size of a shoe box to be sent into space – has recently settled their European office at the International Space University’s (ISU) central campus in Strasbourg, France.
At a recent press event held at ISU, Dr. Paul Kamoun, former ISU faculty, and director of the European branch of SpacePharma said:
“The notoriety of the International Space University, the ISU Incubator, the attractiveness of the Eurometropolis of Strasbourg, and the influence of the health competitiveness cluster “BioValley France” played a major role in SpacePharma’s decision to locate its European office on the central campus of ISU”.
The main reasons why SpacePharma Europe chose to settle at ISU are:
Will tomorrow’s drug treatments be produced in space? “Made in Space” for medicine is a new playground for research and innovation!
“Lack of gravity/microgravity in space, opens the way to innovations in the pharmaceutical domain also, that we could not have imagined on Earth…” as explained by Dr. Paul Kamoun in the documentary by FranceInfo (France 3 GrandEst, starting at 8:13min).
At a recent press event held at ISU, Dr. Paul Kamoun, former ISU faculty, and director of the European branch of SpacePharma said:
“The notoriety of the International Space University, the ISU Incubator, the attractiveness of the Eurometropolis of Strasbourg, and the influence of the health competitiveness cluster “BioValley France” played a major role in SpacePharma’s decision to locate its European office on the central campus of ISU”.
This is an overview of the Space and Clinical Operations Division whose mission is to optimize the health, fitness and well-being of flight crews, their dependents and employees of the Johnson Space Center and White Sands Space Harbor.